Lancet OncolJClub
Global health expenditures on cancer control: a cross-sectional analysis.
The Lancet Oncology · · Journal Article
Figi, Stein + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Nationally reported recurrent expenditure on cancer control is available for 81 of 218 countries and territories, with a mean of $88·9 per capita and strong income-group disparities.
- Why it matters: Global health expenditures on cancer control have not been systematically quantified, limiting benchmarking against cancer incidence and hindering comparable planning across countries.
- What they did: In a cross-sectional study, the team harmonised publicly accessible national health accounts and government sources for 218 countries and territories, converting 77 to 2022 US dollars.
- The result: Mean annual per-capita spending was $173·4 in high-income, $15·7 in upper-middle-income, $3·9 in lower-middle-income, and $0·4 in low-income countries and territories, indicating generally low levels and high variability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.